Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes”
Saved in:
Main Author: | Bo Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Asian Journal of Surgery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958424017822 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study
by: Shan Huang, et al.
Published: (2025-01-01) -
New in recommendations on primary percutaneous coronary intervention for myocardial infarction with ST segment elevation
by: M.Т. Vatutin, et al.
Published: (2016-09-01) -
Association of Serum Gamma-Glutamyltransferase with In-hospital Heart Failure in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: An-Cheng Hou, et al.
Published: (2025-01-01) -
Relationship of ST-segment elevation myocardial infarction with weather and season
by: Okkes Zortuk, et al.
Published: (2024-04-01) -
«No-reflow» phenomenon and risk factors associated with its development after primary percutaneous coronary interventions in patients with ST elevation myocardial infarction
by: V.І. Tseluyko, et al.
Published: (2018-09-01)